-
Product Insights
D4 Dopamine Receptor – Drugs In Development, 2023
Global Markets Direct’s D4 Dopamine Receptor provides in depth analysis on D4 Dopamine Receptor targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in D4 Dopamine Receptor targeted therapeutics...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pipamperone Dihydrochloride in Major Depressive Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pipamperone Dihydrochloride in Major Depressive Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pipamperone Dihydrochloride in Major Depressive Disorder Drug Details: Pipamperone dihydrochloride...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pramipexole in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pramipexole in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pramipexole in Parkinson's Disease Drug Details: Pramipexole is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Levodopa in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Levodopa in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Levodopa in Parkinson's Disease Drug Details: Levodopa is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brilaroxazine in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brilaroxazine in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brilaroxazine in Parkinson's Disease Drug Details: RP-5063 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ND-0612 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ND-0612 in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ND-0612 in Parkinson's Disease Drug Details: ND-0612 is under development as...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brilaroxazine in Psychosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Brilaroxazine in Psychosis Drug Details: RP-5063 is under development for the treatment of schizophrenia, schizoaffective...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brilaroxazine in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brilaroxazine in Pulmonary Arterial Hypertension report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s...
-
Product Insights
Injectable Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Injectable Drug Delivery Pipeline Market Report Overview Injectable drug delivery devices help administer a drug into a patient’s blood. The Injectable Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Sustained Release Injectable...
-
Product Insights
NDS – D1/D4 Bratislava – Triblavina Motorway – Bratislavsky
Equip yourself with the essential tools needed to make informed and profitable decisions with our NDS - D1/D4 Bratislava - Triblavina Motorway - Bratislavsky report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...